A 12-week Digital Physical Activity Programme, With or Without Physical Education Support for Type 2 Diabetes Patients.
- Conditions
- Diabetes Mellitus, Type 2
- Registration Number
- NCT06402578
- Lead Sponsor
- Queen Margaret University
- Brief Summary
Investigation into the effects of a 12-week digital physical activity programme, with or without physical education support on blood glucose control in patients with T2DM using HbA1c testing.
- Detailed Description
Primary objective: investigate the effects of a 12-week digital physical activity programme, with or without physical education support on blood glucose control in patients with T2DM using HbA1c testing. Secondary objective: evaluate the effects on Cholesterol (ratio of High Density Lipids to Low Density Lipids), Resting Heart Rate, and Body Mass Index after a 12 week physical activity programme. Monitor step counts and sleep patterns during a 12 week physical activity programme.: Methods: Using a RCT is intended to implement dependent variable inductive research into a 12-week e-Health Physical activity (PA) programme with or without physical education support focusing on the blood glucose control in patients with T2DM. Recruitment of 60 patients from hospital out-patient clinics, community diabetic departments, and. NHS patients from general practitioners.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 60
- A diagnosis of T2DM in the last 3 years.
- Age 18+ years.
- Uses the English language as a primary or secondary language with the ability to read and write.
- Lives in the United Kingdom.
- Has no medical reason preventing participation in regular physical activity.
- Has a SMART phone with access to the internet.
- Physical inability to participate in 12 weeks of physical activity.
- Cardiac or cardiovascular surgery in the past 6 months.
- Musculoskeletal issues that could be aggravated whilst participating in regular physical activity.
- Presently participating in a weight loss programme.
- Unable to commit to the 12-week feasibility study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method HbA1c testing 12 weeks blood will be take pre and post trial.
- Secondary Outcome Measures
Name Time Method Cholesterol ratio testing 12 weeks blood will be take pre and post trial.
Trial Locations
- Locations (1)
Queen Margret University Edinburgh
🇬🇧Edinburgh, Musselburgh, United Kingdom
Queen Margret University Edinburgh🇬🇧Edinburgh, Musselburgh, United Kingdom